Aditxt, Inc.(ADTX)Earnings, Financials & Key Ratios
ADTX•NASDAQ
$0.12
$60382 mkt cap·Price updated May 7, 2026
AboutAditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.Show more
- Revenue$134K-79.2%
- EBITDA-$27M-6.8%
- Net Income-$34M-6.4%
- EPS (Diluted)-346053.00-38.6%
- Gross Margin-367.95%-2026.0%
- EBITDA Margin-20335.67%-414.1%
- Operating Margin-20796.36%-414.8%
- Net Margin-25708.85%-412.2%
- ROE-283.12%+7.1%
- ROIC-86.1%+11.9%
- Debt/Equity0.84-26.4%
- Interest Coverage-3.78+7.2%
ADTX Key Insights
Aditxt, Inc. (ADTX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 10.7% through buybacks
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 0 (bottom 0%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ADTX Price & Volume
Aditxt, Inc. (ADTX) stock price & volume — 10-year historical chart
Loading chart...
ADTX Growth Metrics
Aditxt, Inc. (ADTX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years8.45%
TTM-97.2%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-5.1%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM99.95%
Return on Capital
10 Years-238.31%
5 Years-238.31%
3 Years-219.44%
Last Year-203.2%
ADTX Peer Comparison
Aditxt, Inc. (ADTX) competitors in Immunology and Inflammation Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 IMMP | 63.65M | 0.43 | -1.42 | 31.28% | -11.72% | -72.51% | 0.01 | |
 CRIS | 75.96M | 0.58 | -0.99 | -13.43% | -80.29% | -138.81% | 0.30 | |
 AGEN | 132.45M | 3.75 | -1102.94 | 10.37% | 0.1% | |||
 NKTR | 1.69B | 83.37 | -8.57 | -43.89% | -297.07% | -399.1% | 1.66 | |
 AIMD | 8.37M | 1.75 | -1.12 | -83.02% | -132.32% | -119.35% | 0.77 | |
 FATE | 280.32M | 2.43 | -2.11 | -51.24% | -20.51% | -65.79% | 0.38 | |
 RCUS | 2.5B | 24.80 | -7.54 | -4.26% | -156.36% | -68.97% | 0.16 | |
 IMVT | 5.53B | 27.22 | -9.97 | -47.07% | 0.00 |
Compare ADTX vs Peers
Aditxt, Inc. (ADTX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ADTX Income Statement
Aditxt, Inc. (ADTX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 105.03K | 933.72K | 645.18K | 133.99K | 5.95K |
| Revenue Growth % | - | - | - | - | - | 788.96% | -30.9% | -79.23% | -97.2% |
| Cost of Goods Sold | 0 | 0 | 0 | 17.77K | 77.98K | 766.78K | 756.84K | 627.47K | 208.89K |
| COGS % of Revenue | - | - | - | - | 74.24% | 82.12% | 117.31% | 468.32% | - |
| Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | -17.77K▲ 0% | 27.05K▲ 252.2% | 166.94K▲ 517.0% | -111.66K▼ 166.9% | -493K▼ 341.5% | -202.94K▲ 0% |
| Gross Margin % | - | - | - | - | 25.76% | 17.88% | -17.31% | -367.95% | -3413.68% |
| Gross Profit Growth % | - | - | - | - | 252.23% | 517.02% | -166.89% | -341.52% | - |
| Operating Expenses | 212.99K | 5.61M | 5.87M | 8.85M | 41.96M | 25.65M | 25.95M | 27.37M | 20.35M |
| OpEx % of Revenue | - | - | - | - | 39950.87% | 2746.77% | 4022.28% | 20427.66% | - |
| Selling, General & Admin | 212.99K | 5.08M | 5.7M | 7.92M | 22.42M | 17.84M | 18.88M | 16.48M | 17.08M |
| SG&A % of Revenue | - | - | - | - | 21344.52% | 1910.11% | 2925.78% | 12302.87% | - |
| Research & Development | 0 | 525K | 175.44K | 937.97K | 5.04M | 7.27M | 7.07M | 10.89M | 3.34M |
| R&D % of Revenue | - | - | - | - | 4801.3% | 778.4% | 1096.5% | 8124.79% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 14.5M | 544.03K | 0 | 0 | -67.88K |
| Operating Income | -213K▲ 0% | -5.61M▼ 2533.3% | -5.87M▼ 4.7% | -8.87M▼ 51.1% | -41.94M▼ 372.7% | -25.48M▲ 39.2% | -26.06M▼ 2.3% | -27.86M▼ 6.9% | -20.55M▲ 0% |
| Operating Margin % | - | - | - | - | -39925.17% | -2728.88% | -4039.58% | -20796.36% | -345705.18% |
| Operating Income Growth % | - | -2533.33% | -4.67% | -51.12% | -372.66% | 39.24% | -2.29% | -6.91% | - |
| EBITDA | 638.94K | 0 | 0 | -8.85M | -41.46M | -24.94M | -25.52M | -27.25M | -20.18M |
| EBITDA Margin % | - | - | - | - | -39471.76% | -2671.48% | -3955.49% | -20335.67% | -339463.57% |
| EBITDA Growth % | - | -100% | - | - | -368.23% | 39.83% | -2.31% | -6.77% | 31.77% |
| D&A (Non-Cash Add-back) | 851.94K | 5.61M | 5.87M | 17.77K | 476.24K | 535.98K | 542.58K | 617.25K | 371.06K |
| EBIT | -213K | -5.61M | -5.83M | -8.84M | -44.43M | -25.36M | -26M | -27.66M | -41M |
| Net Interest Income | 0 | 0 | 0 | -309.52K | -1.94M | -2.23M | -6.38M | -7.36M | -1.84M |
| Interest Income | 0 | 0 | 1.93K | 563 | 3.1K | 57.35K | 10.17K | 1.45K | 262.81K |
| Interest Expense | 0 | 79.77K | 1.93K | 310.08K | 1.94M | 2.29M | 6.39M | 7.36M | 2.1M |
| Other Income/Expense | 0 | -79.77K | 43.07K | -277.02K | -4.44M | -2.17M | -6.33M | -7.16M | -22.55M |
| Pretax Income | -852K▲ 0% | -5.69M▼ 567.7% | -5.83M▼ 2.4% | -9.15M▼ 57.0% | -46.37M▼ 406.8% | -27.65M▲ 40.4% | -32.39M▼ 17.1% | -35.02M▼ 8.1% | -43.1M▲ 0% |
| Pretax Margin % | - | - | - | - | -44148.56% | -2961.29% | -5020.4% | -26137.25% | -725028.83% |
| Income Tax | -852K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -213K▲ 0% | -5.69M▼ 2570.9% | -5.83M▼ 2.5% | -9.15M▼ 56.9% | -46.37M▼ 406.8% | -27.65M▲ 40.4% | -32.38M▼ 17.1% | -34.45M▼ 6.4% | -42.24M▲ 0% |
| Net Margin % | - | - | - | - | -44148.56% | -2961.29% | -5018.92% | -25708.85% | -710498.74% |
| Net Income Growth % | - | -2570.89% | -2.47% | -56.94% | -406.83% | 40.37% | -17.11% | -6.38% | -5.1% |
| Net Income (Continuing) | -213K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.39M | -35.02M | -43.1M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -9.61K | -583.18K | -1.13M |
| EPS (Diluted) | -999999.00▲ 0% | -999999.00▲ 0.0% | -999999.00▲ 0.0% | -1.33▲ 100.0% | -2.43▼ 82.7% | -14.89▼ 512.8% | -249623.74▼ 1676352.2% | -346053.00▼ 38.6% | -964.01▲ 0% |
| EPS Growth % | - | -2570.96% | -2.43% | 100% | -82.71% | -512.76% | -1676352.25% | -38.63% | 99.95% |
| EPS (Basic) | -999999.00 | -999999.00 | -999999.00 | -1.33 | -2.43 | -14.89 | -249623.74 | -346053.00 | - |
| Diluted Shares Outstanding | 0 | 0 | 0 | 6.9M | 19.09M | 1.85M | 131 | 117 | 43.82K |
| Basic Shares Outstanding | 0 | 0 | 0 | 6.9M | 19.09M | 1.85M | 131 | 117 | 43.82K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ADTX Balance Sheet
Aditxt, Inc. (ADTX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 25K | 115.71K | 4.09K | 11.03M | 9.42M | 4.74M | 6.91M | 2M | 420.44K |
| Cash & Short-Term Investments | 25K | 115.71K | 4.09K | 10.5M | 7.87M | 2.77M | 97.1K | 833.03M | 163.04K |
| Cash Only | 25K | 115.71K | 4.09K | 10.5M | 7.87M | 2.77M | 97.1K | 833.03K | 163.04K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 832.2M | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 589.84K | 527.96K | 5.85M | 1.15M | 39.18K |
| Days Sales Outstanding | - | - | - | - | 2.05K | 206.39 | 3.31K | 3.14K | 29.21K |
| Inventory | 0 | 0 | 0 | 0 | 494.7K | 950.09K | 745.5K | 11.24K | 6.57K |
| Days Inventory Outstanding | - | - | - | - | 2.32K | 452.26 | 359.53 | 6.54 | 15.07 |
| Other Current Assets | 0 | 0 | 0 | 384.69K | 0 | 0 | 0 | -885.71M | 149.03K |
| Total Non-Current Assets | 0 | 0 | 119.44K | 2.06M | 7.25M | 5.99M | 37.67M | 30.14M | 11.38M |
| Property, Plant & Equipment | 0 | 0 | 0 | 1.67M | 6.36M | 5.48M | 4.1M | 2.77M | 2.05M |
| Fixed Asset Turnover | - | - | - | - | 0.02x | 0.17x | 0.16x | 0.05x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 321K | 214K | 107K | 9.44K | 6.11K | 3.61K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 22.28M | 27.28M | 91.1M |
| Other Non-Current Assets | 0 | 0 | 119.44K | 72.3K | 668.79K | 405.37K | 11.28M | -310.19K | 2.6M |
| Total Assets | 25K▲ 0% | 115.71K▲ 362.8% | 123.53K▲ 6.8% | 13.1M▲ 10501.7% | 16.66M▲ 27.2% | 10.74M▼ 35.6% | 44.58M▲ 315.3% | 32.14M▼ 27.9% | 11.8M▲ 0% |
| Asset Turnover | - | - | - | - | 0.01x | 0.09x | 0.01x | 0.00x | 0.00x |
| Asset Growth % | - | 362.84% | 6.76% | 10501.71% | 27.24% | -35.58% | 315.25% | -27.89% | -61.53% |
| Total Current Liabilities | 59.9K | 1.65M | 2.98M | 1.23M | 3.61M | 3.64M | 25.89M | 23.41M | 20.66M |
| Accounts Payable | 8.57K | 1.06M | 1.85M | 241.61K | 1.58M | 1.96M | 8.55M | 10.19M | 10.36M |
| Days Payables Outstanding | - | - | - | 4.96K | 7.37K | 932.28 | 4.13K | 5.93K | 16.12K |
| Short-Term Debt | 0 | 163.6K | 165.6K | 587.59K | 700.43K | 409.98K | 16.18M | 5.8M | 5.53M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | -1.58M | -1.96M | 0 | 0 | 0 |
| Other Current Liabilities | 51.33K | 0 | 0 | 6.54K | 1.76M | 2.15M | 158.61K | 4.48M | 4.77M |
| Current Ratio | 0.42x | 0.07x | 0.00x | 8.99x | 2.61x | 1.30x | 0.27x | 0.09x | 0.09x |
| Quick Ratio | 0.42x | 0.07x | 0.00x | 8.99x | 2.47x | 1.04x | 0.24x | 0.08x | 0.08x |
| Cash Conversion Cycle | - | - | - | - | -3.01K | -273.63 | -455.04 | -2.78K | 13.11K |
| Total Non-Current Liabilities | 25K | 1.22M | 0 | 858.06K | 2.88M | 1.89M | 2.64M | 450.87K | 230 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 110.04K | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 858.06K | 2.77M | 1.89M | 1.04M | 436.35K | 827K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 25K | 0 | 0 | 0 | 0 | 0 | 1.6M | 14.52K | 16.51K |
| Total Liabilities | 84.9K | 1.65M | 2.98M | 2.09M | 6.48M | 5.53M | 28.53M | 23.86M | 20.66M |
| Total Debt | 0 | 163.6K | 165.6K | 1.84M | 4.72M | 3.38M | 18.22M | 6.92M | 5.53M |
| Net Debt | -25K | 47.89K | 161.51K | -8.66M | -3.15M | 613.22K | 18.12M | 6.09M | 5.36M |
| Debt / Equity | - | - | - | 0.17x | 0.46x | 0.65x | 1.14x | 0.84x | 0.84x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | -0.27x |
| Net Debt / EBITDA | -0.04x | - | - | - | - | - | - | - | -0.27x |
| Interest Coverage | - | -70.32x | -3041.86x | -28.61x | -21.63x | -11.15x | -4.08x | -3.78x | -19.48x |
| Total Equity | -59.9K▲ 0% | -1.54M▼ 2465.5% | -2.85M▼ 85.6% | 11.01M▲ 486.1% | 10.18M▼ 7.5% | 5.21M▼ 48.9% | 16.05M▲ 208.2% | 8.29M▼ 48.4% | -8.86M▲ 0% |
| Equity Growth % | - | -2465.5% | -85.6% | 486.07% | -7.54% | -48.86% | 208.22% | -48.36% | -197.23% |
| Book Value per Share | - | - | - | 1.60 | 0.53 | 2.81 | 122494.42 | 71060.39 | -202.19 |
| Total Shareholders' Equity | -59.9K | -1.54M | -2.85M | 11.01M | 10.18M | 5.21M | 16.06M | 8.87M | -7.73M |
| Common Stock | 7.1K | 7.53K | 3.92K | 13.08K | 44.53K | 4.31K | 1.32K | 130 | 51 |
| Retained Earnings | -212.99K | -5.9M | -11.73M | -20.88M | -67.35M | -95.04M | -127.74M | -168.09M | -205.11M |
| Treasury Stock | 0 | 0 | -189.63K | -201.6K | -201.6K | -201.6K | -201.6K | -201.6K | -201.6K |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -9.61K | -583.18K | -1.13M |
ADTX Cash Flow Statement
Aditxt, Inc. (ADTX) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 0 | -386.26K | -464.35K | -7.22M | -22.28M | -22.39M | -18.58M | -16.76M | -16.76M |
| Operating CF Margin % | - | - | - | - | -21210.41% | -2398.16% | -2879.34% | -12510.45% | - |
| Operating CF Growth % | - | - | -20.22% | -1455.07% | -208.52% | -0.51% | 17.04% | 9.77% | -185.56% |
| Net Income | -851.94K | -5.69M | -5.83M | -9.15M | -46.37M | -27.65M | -32.38M | -34.45M | -42.24M |
| Depreciation & Amortization | 0 | 0 | 0 | 17.77K | 476.24K | 535.98K | 542.58K | 617.25K | 371.33K |
| Stock-Based Compensation | 612.34K | 3.52M | 4.23M | 3.19M | 4.64M | 3.13M | 1.4M | 6.75M | 477.68K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 17M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 34.26K | 350.51K | 0 | 300K | 1.85M | 2.08M | 2.76M | 3.23M | 22.2M |
| Working Capital Changes | 205.34K | 1.43M | 1.13M | -1.58M | 129.97K | -493.44K | 9.1M | 7.09M | -2.53M |
| Change in Receivables | 0 | 0 | 0 | 0 | -89.84K | -36.77K | 119.64K | 364.89K | 312.52K |
| Change in Inventory | 0 | 0 | 0 | 0 | -494.7K | -455.4K | 204.59K | 734.26K | 82.42K |
| Change in Payables | 0 | 1.05M | 601.61K | -1.48M | 1.33M | 412.96K | 6.65M | 5.1M | -3.76M |
| Cash from Investing | 0 | 0 | 0 | -170.63K | -16.31M | -241.92K | -14.41K | -5M | -2.74M |
| Capital Expenditures | 0 | 0 | 0 | -170.63K | -1.02M | -367.08K | -14.41K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | 967.07% | 39.31% | 2.23% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.26M |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -15.29M | 125.16K | 0 | 0 | 0 |
| Cash from Financing | 100K | 476.97K | 352.73K | 17.89M | 35.95M | 17.53M | 16.55M | 22.5M | 27.59M |
| Debt Issued (Net) | 0 | 119.5K | 2K | -354.07K | 3.56M | -411.89K | 4.86M | -1.4M | -13.46M |
| Equity Issued (Net) | 0 | 631.22K | 470.18K | 18.29M | 29.87M | 17.23M | 11.05M | 18.31M | 39.45M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.71M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -20K | -1K | -2.85M | 308K |
| Other Financing | 100K | -273.75K | -119.44K | -45K | 2.53M | 709.08K | 627.86K | 5.58M | 4.31M |
| Net Change in Cash | 100K▲ 0% | 90.71K▼ 9.3% | -111.62K▼ 223.1% | 10.5M▲ 9504.1% | -2.63M▼ 125.0% | -5.1M▼ 94.1% | -2.67M▲ 47.7% | 735.93K▲ 127.5% | -165.56K▲ 0% |
| Free Cash Flow | 0▲ 0% | -386.26K▲ 0% | -464.35K▼ 20.2% | -7.39M▼ 1491.8% | -23.29M▼ 215.1% | -22.76M▲ 2.3% | -18.59M▲ 18.3% | -16.76M▲ 9.8% | -22.59M▲ 0% |
| FCF Margin % | - | - | - | - | -22177.48% | -2437.48% | -2881.57% | -12510.45% | -379977.73% |
| FCF Growth % | - | - | -20.22% | -1491.82% | -215.14% | 2.3% | 18.31% | 9.84% | -62.23% |
| FCF per Share | - | - | - | -1.07 | -1.22 | -12.27 | -141917.69 | -143744.38 | -143744.38 |
| FCF Conversion (FCF/Net Income) | - | 0.07x | 0.08x | 0.79x | 0.48x | 0.81x | 0.57x | 0.49x | 0.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 612.88K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ADTX Key Ratios
Aditxt, Inc. (ADTX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -224.26% | -437.62% | -359.39% | -304.72% | -283.12% | -621.48% |
| Return on Invested Capital (ROIC) | - | - | - | -670.76% | -297.44% | -97.77% | -86.1% | -86.1% |
| Gross Margin | - | - | - | 25.76% | 17.88% | -17.31% | -367.95% | -3413.68% |
| Net Margin | - | - | - | -44148.56% | -2961.29% | -5018.92% | -25708.85% | -710498.74% |
| Debt / Equity | - | - | 0.17x | 0.46x | 0.65x | 1.14x | 0.84x | 0.84x |
| Interest Coverage | -70.32x | -3041.86x | -28.61x | -21.63x | -11.15x | -4.08x | -3.78x | -19.48x |
| FCF Conversion | 0.07x | 0.08x | 0.79x | 0.48x | 0.81x | 0.57x | 0.49x | 0.53x |
| Revenue Growth | - | - | - | - | 788.96% | -30.9% | -79.23% | -97.2% |
ADTX Frequently Asked Questions
Aditxt, Inc. (ADTX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Aditxt, Inc. (ADTX) reported $0.0M in revenue for fiscal year 2024.
Aditxt, Inc. (ADTX) saw revenue decline by 79.2% over the past year.
Aditxt, Inc. (ADTX) reported a net loss of $42.2M for fiscal year 2024.
Dividend & Returns
Aditxt, Inc. (ADTX) has a return on equity (ROE) of -283.1%. Negative ROE indicates the company is unprofitable.
Aditxt, Inc. (ADTX) had negative free cash flow of $22.6M in fiscal year 2024, likely due to heavy capital investments.
Explore More ADTX
Aditxt, Inc. (ADTX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates